Dr. Skrahina Volha

Dr. Skrahina Volha has a diverse work experience in various roles and positions. In 2013, they worked as an Undergraduate Student Employee at Wacker Chemical Corporation. From 2012 to 2018, they served as a PHD Student at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute. In 2018, Dr. Volha joined CENTOGENE as a Clinical Research Associate and later became a Team Leader Clinical Studies. From 2019 to 2021, they held the position of Director Clinical Studies at CENTOGENE. Currently, they are working at Arcensus Diagnostics as the Senior Director Clinical Programs, starting in April 2021.

Dr. Skrahina Volha began their education in 2007 at Belarusian State University, where they completed a Master's degree in Biology and Chemistry. From 2008 to 2011, they also worked as an Undergraduate Student Researcher at the Republican Theoretical and Practical Centre "Mother and Child". In 2011, they undertook an internship as a School Teacher of Biology. Additionally, they were an Undergraduate Student Researcher at the Max Planck Institute for Infection Biology. The end year for their education at the Max Planck Institute is not specified.